ASeq Newsletter

The ASeq Newsletter explores advancements and challenges within the sequencing technology landscape, focusing on industry dynamics, clinical applications, and market competition. It critically examines the role of major companies like Illumina, emerging technologies, and the impact of sequencing in diagnostics and oncology.

Sequencing Technology Genetics and Diagnostics Market Dynamics Clinical Applications Industry Analysis Technological Innovations Company Profiles

The hottest Substack posts of ASeq Newsletter

And their main takeaways
29 implied HN points 28 Dec 23
  1. The 10X Chromium Controller component cost is likely less than $5000, significantly lower than its original $35000 price tag.
  2. The key components like Thomas diaphragm pumps range from $200 to $400, making up a portion of the instrument's cost.
  3. Through further cost optimization, it's possible to produce a comparable instrument for much less than $5000.
14 implied HN points 08 Feb 24
  1. Death can be understood in different categories like reversible/natural or irreversible/catastrophic.
  2. Chapter 11 bankruptcy involves a compromise between a debtor and creditors to reorganize a company.
  3. The concept of a 'forever company' raises questions about the necessity of companies dying for market evolution.
14 implied HN points 06 Feb 24
  1. Singular Genomics announced a new spatial instrument called G4X for spatial analysis via in situ sequencing using RNA templates.
  2. The G4X technology is similar to 10X Xenium but appears more limited in terms of addressable targets per cell compared to Xenium.
  3. There are concerns about potential patent issues with 10X's spatial patents and ReadCoor IP, raising commercial uncertainties despite the neat research and technology aspects.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
21 implied HN points 11 Jan 24
  1. Oxford Nanopore has about 3.5 years of cash runway based on their current financial situation.
  2. The company received significant amounts of money outside of product sales which impacted their financial numbers.
  3. Oxford Nanopore's growth trajectory and accuracy claims may not align with their goals of surpassing Illumina in the market.
43 implied HN points 15 Nov 23
  1. HiSeq X uses an external compute server compared to MiSeq's internal computer setup.
  2. HiSeq X has larger storage volumes in various RAID configurations than MiSeq.
  3. HiSeq X offers about 4x the compute performance of MiSeq, while NovaSeq 6000 is 7 times faster than HiSeq X.
29 implied HN points 13 Dec 23
  1. The HiSeq X DNA sequencer contains about 100 meters of tubing inside for its fluidics system.
  2. The majority of the tubing in the HiSeq X appears to be around 1.5mm OD and 1mm ID, possibly made of PTFE.
  3. The fluidic path of the HiSeq X is structured similarly to the Solexa Genome Analyzer and uses components from the same vendors.
43 implied HN points 03 Nov 23
  1. Improvement in DNA sequencing has been slow compared to advancements in other industries like semiconductors
  2. Illumina's best selling sequencer is aging and there's a lack of significant competition in the market
  3. Technological advancements in sequencing are mainly incremental, with a focus on adding more cameras and making flow cells bigger
80 implied HN points 19 Aug 23
  1. King Flatley ruled the kingdom of Illumina for 17 years, but an evil wizard infiltrated causing chaos.
  2. The evil wizard DeSouza's reign of terror led to the kingdom's downfall as he sought the power of the Holy GRAIL.
  3. Prince Icahn rose to challenge DeSouza, leading to a battle that ultimately determined the fate of Illumina.
65 implied HN points 23 Aug 23
  1. The post discusses a poll for what people want in a sequencer, without vendors guiding the surveys.
  2. Considerations in the polls include the idea of a sequencer being identical except for one magical different feature from a new vendor.
  3. The poll asks if you would definitely buy the sequencer, potentially changing a planned purchasing decision.
65 implied HN points 20 Aug 23
  1. Some companies are introducing products to compete with Illumina's MiSeq in the lower end of the sequencing market, but they may not pose a strong challenge.
  2. A recent post on GenomeWeb discussed the emergence of kits and instruments targeting the low-throughput market.
  3. The competition to Illumina's dominance at the lower end of the sequencing market continues to evolve.
58 implied HN points 27 Aug 23
  1. Illumina does not provide public disclosure on reagent volumes, but you can measure them from kits.
  2. Recipe files for different Illumina sequencing platforms are available online to guide reagent amounts for the flowcell.
  3. A Google doc has extracted reagent steps for a deblock/incorporation cycle from various Illumina recipe files.
51 implied HN points 11 Sep 23
  1. The post is about the NextSeq 550 Imaging System.
  2. The author discusses a HiSeq imaging module listing on eBay.
  3. The post is available only for paid subscribers.
58 implied HN points 04 Aug 23
  1. PacBio is acquiring Apton BioSystems for approximately $110M to enhance their sequencing technology.
  2. The acquisition of Apton seems strategic for PacBio to develop a competitive high-throughput sequencing instrument.
  3. PacBio's new instrument lineup includes a range of sequencers from mid-range short reads to high-throughput long reads.
58 implied HN points 31 Jul 23
  1. Funding for surveillance is lacking, so focusing on diagnostics may not be practical.
  2. Existing methods can detect new pathogens, reducing the need for meta-genomic sequencing.
  3. Challenges exist in making meta-genomic sequencing platforms affordable and appealing compared to traditional methods.
14 implied HN points 15 Dec 23
  1. The HiSeq X optical system uses TDI imaging to scan across the surface and build up an image line by line.
  2. The system reads out 4 different emission colors which complicates the imaging process.
  3. Various components like ND filters, Powell lens, laser shutter, and dichroic mirror/filter play key roles in enabling accurate imaging on the HiSeq X optical system.
36 implied HN points 04 Sep 23
  1. The MiSeq is one of Illumina's longest read sequencers.
  2. Illumina released the MiSeq to compete with Ion Torrent sales.
  3. The MiSeq is the oldest next-gen sequencer in the market, released in 2011.
14 implied HN points 11 Dec 23
  1. Repeat expansions can be studied through long and short read sequencing to observe differences.
  2. FMR1 gene on the X chromosome can lead to fragile X syndrome due to repeat expansions.
  3. Sequencing technologies like PacBio provide clearer results for repeat expansions compared to short-read data.
14 implied HN points 10 Dec 23
  1. The term 'TechBio' may seem superficial, but technology development in biology is complex and involves a mix of disciplines.
  2. The first qPCR machine from 1992 involved intricate instrumentation like photomultiplier tubes and a variety of electronic components.
  3. The development of technology in biology requires navigating complexity and balancing biochemistry and detection techniques to meet market demands.
21 implied HN points 02 Nov 23
  1. The MiSeq instrument by Illumina uses LEDs for excitation, which are cost-effective compared to lasers.
  2. The LEDs used include a photodiode for power monitoring and specific LEDs like the OSRAM green LED and Luminus red LED.
  3. Overall, the LED-based assembly in MiSeq replaces expensive lasers with affordable components, making it a cost-effective solution in sequencing tools.
14 implied HN points 06 Dec 23
  1. Bought an old MiSeq on eBay, faced issues like getting reagents from Illumina and shipping to Japan but managed to resolve them
  2. Had to reset the password for the MiSeq, managed it by using a Linux system to reset and configure passwords
  3. Prepped PhiX control, ran a sequencing run with over-clustered results, but was able to get 20+ bases aligned to PhiX
29 implied HN points 14 Sep 23
  1. PacBio's raw accuracy has only slightly improved over 4 generations of instruments.
  2. Fundamental issues, like polymerase kinetics, may be limiting the accuracy of PacBio sequencing.
  3. PacBio has prioritized longer read lengths over accuracy, using cyclic consensus sequencing for improved results.
14 implied HN points 06 Nov 23
  1. DNA sequencers are expensive due to economies of scale, unlike digital cameras that benefit from mass production.
  2. Cheap DNA sequencers could greatly benefit society, but creating them poses technical and sociological challenges.
  3. The cost of components for DNA sequencers, like cameras in the MiSeq, can be broken down to see how much they contribute to the overall expensive price.
14 implied HN points 10 Oct 23
  1. Genus Plc focuses on agricultural biotech products, particularly in pig and bovine semen.
  2. They offer Intelligen sexing technologies for selecting the sex of offspring in animals.
  3. The use of similar sex selection technologies in humans raises ethical concerns and has varying levels of effectiveness.
21 implied HN points 13 Aug 23
  1. Singular Genomics is struggling with low share price and few instrument sales.
  2. Proposed solution is to develop a cheap MiSeq-class sequencer to target the lower end of the market.
  3. By focusing on cost-effective instrument with minimal field support, the company aims to attract small labs and researchers.
7 implied HN points 29 Nov 23
  1. Short reads can address a large portion of the human genome efficiently.
  2. Long reads allow us to tackle 5-10% of the genome that short reads alone cannot.
  3. Analyzing genome uniqueness and repeat structure helps evaluate new approaches in genomics.
7 implied HN points 24 Nov 23
  1. HiSeq X cameras use TDI imaging for capturing images.
  2. HiSeq X cameras have two independent sensors each, totaling 4 sensors for 4 color chemistry.
  3. Proper illumination and filtering techniques are crucial to prevent photo-damage in HiSeq X cameras.